NasdaqCM - Delayed Quote USD

Celcuity Inc. (CELC)

15.92 +0.15 (+0.95%)
At close: April 26 at 4:00 PM EDT
15.92 0.00 (0.00%)
After hours: April 26 at 4:20 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
66,230.33
66,230.33
39,391.09
28,355.92
9,556.16
Operating Income
-66,230.33
-66,230.33
-39,391.09
-28,355.92
-9,556.16
Net Non Operating Interest Income Expense
2,451.22
2,451.22
-978.95
-1,249.09
81.99
Other Income Expense
--
--
--
-0.26
--
Pretax Income
-63,779.12
-63,779.12
-40,370.04
-29,605.27
-9,474.18
Net Income Common Stockholders
-63,779.12
-63,779.12
-40,370.04
-29,605.27
-9,474.18
Diluted NI Available to Com Stockholders
-63,779.12
-63,779.12
-40,370.04
-29,605.27
-9,474.18
Basic EPS
-2.69
--
-2.64
-2.21
-0.92
Diluted EPS
-2.69
--
-2.64
-2.21
-0.92
Basic Average Shares
23,679.47
--
15,418.54
13,382.55
10,266.88
Diluted Average Shares
23,679.47
--
15,418.54
13,382.55
10,266.88
Total Operating Income as Reported
-66,230.33
-66,230.33
-39,391.09
-28,355.92
-9,556.16
Total Expenses
66,230.33
66,230.33
39,391.09
28,355.92
9,556.16
Net Income from Continuing & Discontinued Operation
-63,779.12
-63,779.12
-40,370.04
-29,605.27
-9,474.18
Normalized Income
-63,779.12
-63,779.12
-40,370.04
-29,605.00
-9,474.18
Interest Income
7,777.60
7,777.60
1,127.16
13.26
82.11
Interest Expense
5,326.39
5,326.39
2,106.11
1,262.35
0.12
Net Interest Income
2,451.22
2,451.22
-978.95
-1,249.09
81.99
EBIT
-58,452.73
-58,452.73
-38,263.93
-28,342.92
-9,474.06
EBITDA
-58,309.96
-58,309.96
-38,053.01
-28,039.68
-9,088.46
Reconciled Depreciation
142.77
142.77
210.92
303.24
385.59
Net Income from Continuing Operation Net Minority Interest
-63,779.12
-63,779.12
-40,370.04
-29,605.27
-9,474.18
Total Unusual Items Excluding Goodwill
--
--
--
-0.26
--
Total Unusual Items
--
--
--
-0.26
--
Normalized EBITDA
-58,309.96
-58,309.96
-38,053.01
-28,039.42
-9,088.46
12/31/2020 - 9/20/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ZNTL Zentalis Pharmaceuticals, Inc.
11.06
+0.68%
 
AVTE Aerovate Therapeutics, Inc.
21.75
+0.83%
 
ORIC ORIC Pharmaceuticals, Inc.
8.07
+5.22%
 
FULC Fulcrum Therapeutics, Inc.
7.14
+0.14%
 
CGEM Cullinan Therapeutics, Inc.
25.30
+31.43%
 
APGE Apogee Therapeutics, Inc.
47.13
+2.77%
 
TRVI Trevi Therapeutics, Inc.
2.7800
+9.45%
 
SNTI Senti Biosciences, Inc.
0.2900
+4.05%
 
PRLD Prelude Therapeutics Incorporated
4.0700
+0.74%
 
VRAX Virax Biolabs Group Limited
0.6900
-1.71%